Structure-based substrate screening for an enzyme

BMC Bioinformatics

Volumn 10, Issue , 2009, Pages 257-

  Xu, Tao ^a   Zhang, Lujia ^a   Wang, Xuedong ^a   Wei, Dongzhi ^a   Li, Tianbi ^b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ROTHAMSTED RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ANTARCTICA LIPASE B; CARBONYL GROUPS; COMPUTATIONAL SKILLS; ENZYME STRUCTURES; GENETIC OPERATIONS; MOLECULAR DOCKING; MOLECULAR RECOGNITION MECHANISM; SCREENING SYSTEM;

ATOMS; CARBONYL COMPOUNDS; DRUG DELIVERY; ENZYMES; OXYGEN;

SUBSTRATES;

IMIDAZOLE; LIPASE B;

ACCURACY; ARTICLE; CANDIDA ANTARCTICA; COMPUTER ANALYSIS; COMPUTER MODEL; COMPUTER PREDICTION; ENZYME ANALYSIS; ENZYME CONFORMATION; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; HIGH THROUGHPUT SCREENING; MOLECULAR DOCKING; RELIABILITY; STRUCTURE ANALYSIS;

BINDING SITES; COMPUTATIONAL BIOLOGY; DRUG DESIGN; LIGANDS; MODELS, MOLECULAR; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

CANDIDA ANTARCTICA;

EID: 70349737917     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-10-257     Document Type: Article

References (34)

1. Yingkai Z, Haiyan L, Weitao Y. Free energy calculation on enzyme reactions with an efficient iterativeprocedure to determine minimum energy paths on a combined ab initio QM/MM potential energy surface. J Chem Phys 2002, 112:3483-3491.
2. Robertson D.E, Steer B.A. Recent progress in biocatalyst discovery and optimization. Curr Opin Che Biol 2004, 8:141-149.
3. Lorenz P, Schleper C. Metagenome: a challenging source of enzyme discovery. J Mol Catal B: Enzym 2002, 19-20:13-19.
4. Jestin J.L, Vichier G.S. How to broaden enzyme substrate specificity: strategies, implications and applications. Res Microbiol 2005, 156:961-966. 10.1016/j.resmic.2005.09.004, 16293399.
5. Marshall G.R. Computer-Aided Drug Design. Ann Rev Pharmacol Toxical 1987, 27:193-213.
6. Lecaille F, Kaleta J, Brömme D. Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem Rev 2002, 102:4459-4488. 10.1021/cr0101656, 12475197.
7. Ring C.S, Sun E, McKerrow J.H, Lee G.K, Rosenthal P.J, Kuntz I.D, Cohen F.E. Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc Natl Acad Sci USA 1993, 90:3583-3587. 10.1073/pnas.90.8.3583, 46345, 8475107.
8. Lin T.W, Melgar M.M, Kurth D, Swamidass S.J, Purdon J, Tseng T, Gago G, Baldi P, Gramajo H, Tsai S.C. Structure-based inhibitor design of AccD5, an essential acyl-CoA carboxylase carboxyltransferase domain of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2006, 103:3072-3077. 10.1073/pnas.0510580103, 1413898, 16492739.
9. Kumaran D, Rawat R, Ludivico M.L, Ahmed S.A, Swaminathan S. Structure and substrate based inhibitor design for clostridium botulinum neurotoxin serotype A. J Biol Chem 2008, 283:18883-18891. 10.1074/jbc.M801240200, 18434312.
10. Taft C.A, Da Silva V.B, Da Silva C.H. Current topics in computer-aided drug design. J Pharm Sci 2008, 97:1089-1098. 10.1002/jps.21293, 18214973.
11. Veselovsky A.V, Ivanov A.S. Strategy of computer-aided drug design. Curr Drug Targets Infect Disord 2003, 3:33-40. 10.2174/1568005033342145, 12570731.
12. Jackson R.C. Update on computer-aided drug design. Curr Opin Biotechnol 1995, 6:646-651. 10.1016/0958-1669(95)80106-5, 8527834.
13. Li J.J, Nahra J, Johnson A.R, Bunker A, O'Brien P, Yue W.S, Ortwine D.F, Man C.F, Baragi V, Kilgore K, Dyer R.D, Han H.K. Quinazolinones and pyrido [3,4-d] pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis. J Med Chem 2008, 51:835-841. 10.1021/jm701274v, 18251495.
14. Park H, Jeon Y.H. Toward the virtual screening of Cdc25A phosphatase inhibitors with the homology modeled protein structure. J Mol Model 2008, 14(9):833-841. 10.1007/s00894-008-0311-2, 18504625.
15. Cogan D.A, Aungst R, Breinlinger E.C, Fadra T, Goldberg D.R, Hao M.H, Kroe R, Moss N, Pargellis C, Qian K.C, Swinamer A.D. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase. Bioorg Med Chem Lett 2008, 18:3251-3255. 10.1016/j.bmcl.2008.04.043, 18462940.
16. Chen X, Zhong S, Zhu X, Dziegielewska B, Ellenberger T, Wilson G.M, MacKerell A.D, Tomkinson A.E. Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res 2008, 68:3169-3177. 10.1158/0008-5472.CAN-07-6636, 18451142, 2734474.
17. Mohan V, Gibbs A.C, Cummings M.D, Jaeger E.P, DesJarlais R.L. Docking: successes and challenges. Curr Pharm Des 2005, 11:323-333. 10.2174/1381612053382106, 15723628.
18. Warren G.L, Andrews C.W, Capelli A.M, Clarke B, LaLonde J, Lambert M.H, Lindvall M, Nevins N, Semus S.F, Senger S, Tedesco G, Wall I.D, Woolven J.M, Peishoff C.E, Head M.S. A critical assessment of docking programs and scoring functions. J Med Chem 2006, 49:5912-5931. 10.1021/jm050362n, 17004707.
19. Kroemer R.T. Structure-based drug design: docking and scoring. Curr Protein Pept Sci 2007, 8(4):312-328. 10.2174/138920307781369382, 17696866.
20. Mulholland A.J. Modelling enzyme reaction mechanisms, specificity and catalysis. Drug Discov Today 2005, 10(20):1393-1402. 10.1016/S1359-6446(05)03611-1, 16253878.
21. Hu C.H, Brinck T, Hult K. Ab Initio and Density Functional Theory Studies of the Catalytical Mechanism for Ester Hydrolysis in Serine Hydrolase. International journal of quantum chemistry 1998, 69:89-103.
22. Gao B, Su E.Z, Lin J.P, Jiang Z.B, Ma Y.S, Wei D.Z. Development of recombinant Escherichia coli whole-cell biocatalyst expressing a novel alkaline lipase-coding gene from Proteus sp. for biodiesel production. J Biotech 139(2):169-175.
23. Rotticci D, Rotticci-Mulder J.C, Denman S, Norin T, Hult K. Improved enantioselectivity of a lipase by rational protein engineering. Chembiochem 2001, 2:766-770. 10.1002/1439-7633(20011001)2:10<766::AID-CBIC766>3.0.CO;2-K, 11948859.
24. Magnusson A.O, Rotticci-Mulder J.C, Santagostino A, Hult K. Creating space for large secondary alcohols by rational redesign of Candida antarctica lipase B. Chembiochem 2001, 6:1051-1056.
25. Uppenberg J, Hansen M.T, Patkar S, Jones T.A. The sequence, crystal structure determination and refinement of two crystal formsof lipase B from Candida antarctica. Structure 1994, 2:293-308. 10.1016/S0969-2126(00)00031-9, 8087556.
26. Uppenberg J, Ohrner N, Norin M, Hult K, Kleywegt G.J, Patkar S, Waagen V, Anthonsen T, Jones T.A. Crystallographic and molecular-modeling studies of lipase B from Candida antarctica reveal a stereospecificity pocket for secondary alcohols. Biochemistry 1995, 34:16838-16851. 10.1021/bi00051a035, 8527460.
27. Halperin I, Ma B, Wolfson H, Nussinov R. Principles of docking: An overview of search algorithms and a guide to scoring functions. Proteins 2002, 47:409-443. 10.1002/prot.10115, 12001221.
28. Kitchen D.B, Decornez H, Furr J.R, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 2004, 3:935-949. 10.1038/nrd1549, 15520816.
29. Kellenberger E, Rodrigo J, Muller P, Rognan D. Comparative evaluation of eight docking tools for docking and virtual screening accuracy. Proteins 2004, 57:225-242. 10.1002/prot.20149, 15340911.
30. Bursulaya B.D, Totrov M, Abagyan R, Brooks C.L. Comparative study of several algorithms for flexible ligand docking. J Comput Aided Mol Des 2003, 17:755-763. 10.1023/B:JCAM.0000017496.76572.6f, 15072435.
31. Gotor Fernandez V, Busto E, Gotor V. Candida antarctica lipase B: An ideal biocatalyst for the preparation of nitrogenated organic compounds. Advanced synthesis & catalysis 2006, 348:797-812.
32. Schulz T, Pleiss J, Schmid R.D. Stereoselectivity of Pseudomonas cepacia lipase toward secondary alcohols: a quantitative model. Protein Sci 2000, 9:1053-1062. 2144656, 10892799, 10.1110/ps.9.6.1053.
33. Bodi A. van der Waals Volumes and Radii. J Phys Chem 1964, 68:441-442.
34. Rowland R.S, Taylor R. Intermolecular Nonbonded Contact Distances in Organic Crystal Structures: Comparison with Distances Expected from van der Waals Radii. J Phys Chem 1967, 100:7384-7391.